内科合并症影响全髋关节置换术的围手术期报销费用
该回顾性、证据等级III研究利用PearlDiver超级计算机识别2007年至2015年间接受初次全髋关节置换术的患者,按内科合并症分层,比较手术当日及术后90天内的报销费用。共纳入250343例患者。手术当日报销费用最高的合并症为肝硬化、病态肥胖、肥胖、慢性肾脏病(CKD)和丙型肝炎;术后90天报销费用最高的合并症为肝硬化、丙型肝炎、慢性阻塞性肺疾病、心房颤动和CKD。结论认为内科合并症显著影响全髋关节置换术后的报销费用,并据以推断影响实际成本。
要点
- 手术当日报销费用最高的合并症包括肝硬化、病态肥胖、肥胖、CKD和丙型肝炎。
- 术后90天报销费用最高的合并症包括肝硬化、丙型肝炎、COPD、心房颤动和CKD。
- 内科合并症显著影响全髋关节置换术后的报销费用,并据以推断影响成本。
核心结论
- 内科合并症显著影响全髋关节置换术后的报销费用,并据以推断影响成本。
- 术后90天成本最高的合并症包括肝硬化、丙型肝炎、慢性阻塞性肺疾病、心房颤动和CKD。
研究设计与样本
- 回顾性、证据等级III研究,使用PearlDiver超级计算机识别2007年至2015年间接受初次全髋关节置换术的患者。
- 患者按内科合并症分层,采用方差分析比较手术当日及术后90天内的报销费用。
- 共纳入250343例患者。
主要发现
- 手术当日报销费用最高的合并症为肝硬化、病态肥胖、肥胖、慢性肾脏病(CKD)和丙型肝炎。
- 术后90天报销费用最高的合并症为肝硬化、丙型肝炎、慢性阻塞性肺疾病、心房颤动和CKD。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Total hip arthroplasty (THA) costs are a source of great interest in the currently evolving health care market. The initiation of a bundled payment system has led to further research into costs drivers of this commonly performed procedure. One aspect that has not been well studied is the effect of comorbidities on the reimbursements of THA. The purpose of this study was to determine if common medical comorbidities affect these reimbursements. METHODS: A retrospective, level of evidence III study was performed using the PearlDiver supercomputer to identify patients who underwent primary THA between 2007 and 2015. Patients were stratified by medical comorbidities and compared using the analysis of variance for reimbursements of the day of surgery, and over the 90-day postoperative period. RESULTS: A cohort of 250,343 patients was identified. Greatest reimbursements on the day of surgery were found among patients with a history of cirrhosis, morbid obesity, obesity, chronic kidney disease (CKD) and hepatitis C. Patients with cirrhosis, hepatitis C, chronic obstructive pulmonary disease, atrial fibrillation, and CKD incurred in the greatest reimbursements over the 90-day period after surgery. CONCLUSION: Medical comorbidities significantly impact reimbursements, and inferentially costs, after THA. The most costly comorbidities at 90 days include cirrhosis, hepatitis C, chronic obstructive pulmonary disease, atrial fibrillation, and CKD.
引用
- Rosas S, Sabeh KG, Buller LT, et al. Medical Comorbidities Impact the Episode-of-Care Reimbursements of Total Hip Arthroplasty. J Arthroplasty. 2017. PMID: 28318861. doi:10.1016/j.arth.2017.02.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。